NCT01745133: Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis |
|
|
| Completed | 4 | 63 | US | vehicle foam, calcipotriene, Sorilux foam 0.005% foam, calcipotriene + clobetasol propionate, Sorilux foam + Olux E foam | Leon Kircik, M.D., Stiefel, a GSK Company | Psoriasis | 05/14 | 08/14 | | |
NCT04571151: Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis |
|
|
| Not yet recruiting | 4 | 30 | US | LEXETTE 0.05% Topical Foam, Halobetasol Propionate Topical Foam, Sorilux 0.005 % Topical Foam, Calcipotriol Foam, Vehicle Foam | Skin Sciences, PLLC | Plaque Psoriasis | 11/21 | 12/21 | | |
